UAB "Renalvita" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 443,838 |
| 25,406 |
| 103,178 |
| 102,800 |
| 5,884 |
| 77.76 |
| 23.16 |
| 151,240 |
| 27,558 |
| 82,331 |
| 96,068 |
| 0.15 |
| 0.18 |
| - |
| - |
| 23.25 |
| 103,178 |
| 2024 |
|---|
| 551,798 |
| 29,367 |
| 147,745 |
| 147,745 |
| 7,863 |
| 82.69 |
| 26.78 |
| 150,931 |
| 34,286 |
| 59,293 |
| 125,438 |
| 0.17 |
| 0.23 |
| - |
| - |
| 26.78 |
| 147,745 |
| 2025 |
|---|
| 545,791 |
| 33,795 |
| 131,270 |
| 110,267 |
| 6,828 |
| 82.55 |
| 20.20 |
| 113,453 |
| 49,645 |
| 33,390 |
| 129,205 |
| 0.15 |
| 0.44 |
| - |
| - |
| 24.05 |
| 131,270 |
| 2025 |
|---|
| 545,791 |
| 33,795 |
| 131,270 |
| 110,267 |
| 6,828 |
| 82.55 |
| 20.20 |
| 113,453 |
| 49,645 |
| 33,390 |
| 129,205 |
| 0.15 |
| 0.44 |
| - |
| - |
| 24.05 |
| 131,270 |
Turnover (€)
2025
Turnover (€)
545,791 €-1 % *
Sales per employee (€)
33,795 €15 % *
Profit before tax (€)
131,270 €-11 % *
Net Profit (€)
110,267 €-25 % *
Profit per employee (€)
6,828 €-13 % *
Total profitability (%)
82.55 %-0.17 % *
Net profitability (%)
20.20 %-24.57 % *
Equity (€)
113,453 €-25 % *
Amounts Payable And Liabilities (€)
49,645 €45 % *
Non-current Assets (€)
33,390 €-44 % *
CurrentAssets (€)
129,205 €3 % *
Working capital requirement
0.15 -11.76 % *
Debt-to-equity ratio
0.44 91.30 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
24.05 %-10.19 % *
EBIT (€)
131,270 €-11 % *
